<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02568059</url>
  </required_header>
  <id_info>
    <org_study_id>MTU-EC-TM-1-179/57</org_study_id>
    <secondary_id>TCTR20150917001</secondary_id>
    <nct_id>NCT02568059</nct_id>
  </id_info>
  <brief_title>The Clinical Safety of Alcoholic Extract Sahastara Remedy of Extract Capsule in Healthy Volunteers</brief_title>
  <official_title>The Clinical Safety of Alcoholic Extract Sahastara Remedy of Extract Capsule in Healthy Volunteers (Clinical Trial Phase I)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thammasat University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thammasat University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The clinical safety of Sahastara remedy alcoholic extract in healthy volunteers.
      Investigators will investigate safety of 100 and 200 mg of Sahastara remedy extract capsule
      in healthy volunteers. This is Clinical trial Phase I.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The sahastara remedy (SHT) is a Thai traditional medicine that is use to relieve pain of
      musculoskeletal problem. There is study shown that SHT extract was not found acute and
      chronic toxicity in rat. However, there is no study regarding safety in human. Thus, this
      study is a clinical trial Phase I that investigate clinical safety of SHT alcoholic extract
      in healthy volunteers. The clinical safety will monitor for 28 days in continuously use of
      100 and 200 mg SHT extraction 3 time a day and after stop intervention for 14 days.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical safety evaluated by History taking, Patient diary note, Physical Examination and Laboratory test including Complete Blood Count (CBC), Renal functions, Liver functions, Lipid profile, Fasting Blood Sugar (FBS), and Urinary analysis</measure>
    <time_frame>14 days while using intervention</time_frame>
    <description>Clinical safety was evaluated changing from baseline by History taking, Patient diary note, Physical Examination and Laboratory test including Complete Blood Count (CBC), Renal functions, Liver functions, Lipid profile, Fasting Blood Sugar (FBS), and Urinary analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical safety evaluated by History taking, Patient diary note, Physical Examination and Laboratory test including Complete Blood Count (CBC), Renal functions, Liver functions, Lipid profile, Fasting Blood Sugar (FBS), and Urinary analysis</measure>
    <time_frame>28 days while using intervention</time_frame>
    <description>Clinical safety was evaluated changing from baseline and 14 days while using intervention by History taking, Patient diary note, Physical Examination and Laboratory test including Complete Blood Count (CBC), Renal functions, Liver functions, Lipid profile, Fasting Blood Sugar (FBS), and Urinary analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical safety evaluated by History taking, Patient diary note, Physical Examination and Laboratory test including Complete Blood Count (CBC), Renal functions, Liver functions, Lipid profile, Fasting Blood Sugar (FBS), and Urinary analysis</measure>
    <time_frame>14 days after stop intervention</time_frame>
    <description>Clinical safety was evaluated changing from baseline,14 days and 28 days while using intervention by History taking, Patient diary note, Physical Examination and Laboratory test including Complete Blood Count (CBC), Renal functions, Liver functions, Lipid profile, Fasting Blood Sugar (FBS), and Urinary analysis</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>100 mg SHT extract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Sahastara remedy alcoholic extract capsule dose 100 mg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>200 mg SHT extract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Sahastara remedy alcoholic extract capsule dose 200 mg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sahastara remedy alcoholic extract</intervention_name>
    <description>comparison of different dose of drug</description>
    <arm_group_label>100 mg SHT extract</arm_group_label>
    <arm_group_label>200 mg SHT extract</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  No pregnancy

          -  No Serious Medical Condition evaluated by Physical Examination and Laboratory results
             in 1 month before study

          -  No Supplementary food and/or Vitamin during the study

          -  Able to follow suggestion during the study

        Exclusion Criteria:

          -  Uncontrolled Hypertension (BP&gt;140/90 mm.Hg.)

          -  BMI &gt; 30

          -  Have serious medical condition including Severe peptic ulcer, congestive heart
             disease, Liver and Renal dysfunction.

          -  On during use medicine including Rifampicin, Phenytoin, Propranolol, Theophylline
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Puritat Kanokkangsadal, M.Sc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Applied Thai Traditional Medicine, Faculty of Medicine, Thammasat University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine, Thammasat University</name>
      <address>
        <city>Klongnueng</city>
        <state>Pathumthani</state>
        <zip>12120</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2015</study_first_submitted>
  <study_first_submitted_qc>October 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 5, 2015</study_first_posted>
  <last_update_submitted>October 17, 2016</last_update_submitted>
  <last_update_submitted_qc>October 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Thammasat University</investigator_affiliation>
    <investigator_full_name>Puritat Kanokkangsadal</investigator_full_name>
    <investigator_title>Department of Applied Thai Traditional Medicine, Faculty of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

